These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
500 related articles for article (PubMed ID: 12381216)
1. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Forman R; Koren G; Shear NH Drug Saf; 2002; 25(13):965-72. PubMed ID: 12381216 [TBL] [Abstract][Full Text] [Related]
2. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia. Kamaliah MD; Zainal D; Mokhtar N; Nazmi N Int J Dermatol; 1998 Jul; 37(7):520-3. PubMed ID: 9679693 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children. Lam NS; Yang YH; Wang LC; Lin YT; Chiang BL J Microbiol Immunol Infect; 2004 Dec; 37(6):366-70. PubMed ID: 15599469 [TBL] [Abstract][Full Text] [Related]
4. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States. Moreau JF; Watson RS; Hartman ME; Linde-Zwirble WT; Ferris LK Pediatr Dermatol; 2014; 31(2):163-8. PubMed ID: 23679157 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Léauté-Labrèze C; Lamireau T; Chawki D; Maleville J; Taïeb A Arch Dis Child; 2000 Oct; 83(4):347-52. PubMed ID: 10999875 [TBL] [Abstract][Full Text] [Related]
7. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017. Su JR; Haber P; Ng CS; Marquez PL; Dores GM; Perez-Vilar S; Cano MV Vaccine; 2020 Feb; 38(7):1746-1752. PubMed ID: 31870573 [TBL] [Abstract][Full Text] [Related]
9. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa]. Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020 [TBL] [Abstract][Full Text] [Related]
10. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Rzany B; Hering O; Mockenhaupt M; Schröder W; Goerttler E; Ring J; Schöpf E Br J Dermatol; 1996 Jul; 135(1):6-11. PubMed ID: 8776350 [TBL] [Abstract][Full Text] [Related]
11. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparative review. Yager JA Vet Dermatol; 2014 Oct; 25(5):406-e64. PubMed ID: 24990284 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital. Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525 [TBL] [Abstract][Full Text] [Related]
13. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475 [TBL] [Abstract][Full Text] [Related]
14. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases]. Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593 [TBL] [Abstract][Full Text] [Related]
15. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center. Gleghorn KL; Voigt C; Kelly B Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145 [TBL] [Abstract][Full Text] [Related]
17. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803 [TBL] [Abstract][Full Text] [Related]
18. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701 [TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome. Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483 [TBL] [Abstract][Full Text] [Related]
20. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction]. Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]